Bayer is looking to leverage artificial intelligence with partner German AI company Aignostics to conduct precision oncology drug research and eventual development, the companies announced Thursday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,